Obakulactone Targets ACOT1 to Fight Arthritis | Health and Fitness News

A breakthrough discovery could soon offer new hope for rheumatoid arthritis sufferers: scientists have identified obakulactone (OL), a compound from traditional Chinese medicine, as a powerful anti-inflammatory agent. OL works by targeting the protein ACOT1 and rebalancing harmful fats in the body, effectively calming the inflammation that ravages joints. In rat studies, OL dramatically reduced swelling, repaired cartilage, and even restored immune organ health. It also slashed key inflammatory markers like IL-6 and TNF-alpha. This deep molecular insight not only reveals OL’s mechanism but also highlights ACOT1 as a promising new drug target — potentially paving the way for smar...